NCT07510334 2026-04-03VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell CarcinomaMayo ClinicPhase 2 Not yet recruiting18 enrolled
NCT07218692 2025-10-20RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on ImmunotherapyCity of Hope Medical CenterPhase 2 Not yet recruiting35 enrolled